N-terminal brain natriuretic peptide used for evaluation of dry weight in patients undergoing maintenance hemodialysis

N-terminal brain natriuretic peptide used for evaluation of dry weight in patients undergoing maintenance hemodialysis

Objective To observe N-terminal brain natriuretic peptide(NT-proBNP) used for evaluation of dry weight in maintenance hemodialysis(MHD) patients and analyze the clinical significance.Methods Forty-eight patients undergoing MHD were divided into dry weight group(n=24)and capacity overload group(n=24)...

Full description

Saved in:

Bibliographic Details
Main Authors:	TANG Xiao-fang, YAN Lian-xi, LI Kang-feng, SHI Ping, YAN Ning, WANG Cheng-shuang, KONG Ru-xi, ZHOU Yu-kun
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Nephrology 2016-01-01
Series:	Linchuang shenzangbing zazhi
Subjects:	Hemodialysis N-terminal brain natriuretic peptide Dry weight
Online Access:	http://www.lcszb.com/thesisDetails?columnId=57918590&Fpath=home&index=0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases
by: A. Ya. Panarina, et al.
Published: (2024-11-01)

Brain natriuretic peptide is a biomarker of atrial fibrillation in hemodialysis patients
by: Ling Yu, et al.
Published: (2025-12-01)

Point-of-care N-terminal pro-brain natriuretic peptide testing in patients with heart failure: data from the DREAM study
by: F. I. Belyalov, et al.
Published: (2024-06-01)

The significance of NT-proBNP decline in the evaluation of heart failure during maintenance hemodialysis
by: LI Ping, et al.
Published: (2019-01-01)

A Clinical Study of the N-Terminal pro-Brain Natriuretic Peptide in Myocardial Injury after Neonatal Asphyxia
by: Rui Zhu, et al.
Published: (2016-04-01)

N-terminal Pro-B-Type Natriuretic Peptide is a Myocardial Biomarker in Pulmonary Sepsis and Septic Shock
by: I. N. Tyurin, et al.
Published: (2022-10-01)

Effect of continuous renal replacement therapy on cardiac function in the maintenance hemodialysis patients with hypotension
by: LI Ping, et al.
Published: (2018-01-01)

Correlation between NT-proBNP and blood pressure variability with cardiovascular events in patients undergoing maintaining hemodialysis
by: GAO Xiang, et al.
Published: (2019-01-01)

NEW POSSIBILITIES FOR EVALUATION OF SEVERITY AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE BASED ON N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE PLASMA LEVEL
by: A. S. Galjavich, et al.
Published: (2016-01-01)

Significance of N-terminal pro-B-type natriuretic peptide levels in lung cancer
by: Sinem İnan, et al.
Published: (2025-01-01)

Serum N‐Terminal Pro‐B‐Type Natriuretic Peptide Is Associated With Insulin Resistance in Chinese: Danyang Study
by: Ziwen Zheng, et al.
Published: (2024-11-01)

Modification of the Association of B-Type Natriuretic Peptides With Mortality and Hospitalization Outcomes by Sex
by: David Bobrowski, MD, et al.
Published: (2025-08-01)

The level of N-terminal pro-brain natriuretic peptide depending on vascular wall condition and bone mass in postmenopausal women
by: I. A. Skripnikova, et al.
Published: (2020-07-01)

N-terminal pro-brain natriuretic peptide in essential arterial hypertension patients: antihypertensive therapy effects
by: A. S. Galyavich, et al.
Published: (2006-10-01)

CLINICAL SIGNIFICANCE OF N-TERMINAL FRAGMENT OF NATRIURETIC PEPTIDE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO DO NOT RECEIVE PATHOGENETIC THERAPY
by: T. A. Panafidina, et al.
Published: (2017-09-01)

Comparison of the prognostic potential of biomechanic stress markers - circulating stromelysin-1, matrix metalloprteinase-9 and N-terminal fragment of brain natriuretic peptide in patients with acute Q-wave myocardial infarction. Results of cohort study
by: T. Samura
Published: (2012-04-01)

ON THE GENETIC REGULATION OF BRAIN NATRIURETIC PEPTIDE LEVEL IN PLASMA OF MEN WITH ESSENTIAL HYPERTENSION
by: I. P. Pashkovа, et al.
Published: (2017-03-01)

Evaluation N-terminal pro-B-type natriuretic peptide and other biochemical parameters in heart failure with or without chronic kidney disease in Kirkuk city
by: Firas Tariq, et al.
Published: (2024-10-01)

Correlation of N-terminal pro-B-type natriuretic peptide with clinical parameters in patients with hypertension
by: Pejović Janko, et al.
Published: (2013-01-01)

GENDER AND AGE DIFFERENCES OF BRAIN NATRIURETIC PEPTIDE CONCENTRATION IN PATIENTS WITH MYOCARDIAL INFARCTION
by: E. N. Usoltseva, et al.
Published: (2014-07-01)

Assessment of glomerular and tubulointerstitial apparatus state depending on the level of the natriuretic peptide in hypertension patients
by: A. I. Chernyavina
Published: (2020-04-01)

Role of natriuretic peptides in the assessment of aortic stenosis severity
by: Davičević Žaklina, et al.
Published: (2010-01-01)

Role of brain natriuretic peptide in the pathogenesis of resistant hypertension
by: K. Yu. Nikolaev, et al.
Published: (2023-02-01)

Correlation between pulmonary to systemic flow ratio and N-terminal Pro-B-type natriuretic peptide level in children with atrial septal defect
by: Li-Chin Liao, et al.
Published: (2025-03-01)

Prediction of Gestational Diabetes Mellitus in The First Trimester: comparison of maternal fetuin-A, N-terminal pro-atrial natriuretic peptide, high-sensitivity C-reactive protein, and fasting glucose levels
by: Saz Jabali, et al.
Published: (2025-04-01)

Awareness, access, and adoption of natriuretic peptides for diagnosis of heart failure
by: Antoni Bayes‐Genis, et al.
Published: (2025-02-01)

Natriuretic peptides and chronic heart failure in arterial hypertension patients
by: Yu. A. Vasuyk, et al.
Published: (2007-04-01)

Prognostic impact of beta‐blocker use by N‐terminal pro‐brain natriuretic peptide level in acute heart failure patients
by: Shin‐Jae Kim, et al.
Published: (2024-12-01)

Effect of six weeks low intensity interval training on expression of atrial and brain natriuretic peptide genes following myocardial infarction in rat
by: mehran ghahremani, et al.
Published: (2019-07-01)

Pro-C-Type Natriuretic Peptide in Women With Angina Pectoris and No Obstructive Coronary Artery Disease
by: Peter D. Mark, MD, PhD, et al.
Published: (2025-07-01)

NATRIURETIC PEPTIDE AND HIS PROGENITORS AS PREDICTORS OF PROGRESSIVE POSTOPERATIVE LEFT VENTRICLE REMODELING IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY
by: S. S. Gutor, et al.
Published: (2013-12-01)

INTEGRATION OF BIOMARKERS INTO THE PRACTICE OF TREATING PATIENTS WITH HEART FAILURE: THE ROLE OF DETERMINING THE BLOOD LEVEL OF NATRIURETIC PEPTIDES
by: S. R. Gilyarevskiy, et al.
Published: (2017-12-01)

Natriuretic peptides modulate monocyte-derived Langerhans cell differentiation and promote a migratory phenotype
by: Dorottya Horváth, et al.
Published: (2025-06-01)

Natriuretic peptides: new challenges — new solutions
by: O. M. Drapkina, et al.
Published: (2021-11-01)

Exploring the association of natriuretic peptides with QTc interval in hemodialysis patients
by: Yoshihiro Matsumoto, et al.
Published: (2025-12-01)

Brain natriuretic peptide, structural and functional cardiac remodeling in chronic heart failure with overweight and obesity
by: V. D. Syvolap, et al.
Published: (2014-06-01)

Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure: a prospective cohort study in Vietnam
by: Chau Minh Truong, et al.
Published: (2025-07-01)

Risk factors and diagnostic value of urinary N-terminal pro-brain natriuretic peptide for verification of heart failure in human immunodeficiency virus-infected patients
by: O. G. Goryacheva, et al.
Published: (2022-03-01)

Brain natriuretic peptide and all-cause mortality in patients treated with haemodialysis
by: Maria K Svensson, et al.
Published: (2025-06-01)

Brain natriuretic peptide: diagnostic and prognostic value in chronic heart failure (a literature review)
by: O. O. Sakovych, et al.
Published: (2024-05-01)